Kintara Therapeutics, Inc. (KTRA) Financials
KTRA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 1.9 million | 2.0 million |
2023-09-30 | 1.5 million | 3.5 million |
2023-06-30 | 4.0 million | 3.2 million |
2023-03-31 | 6.7 million | 3.0 million |
KTRA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -2.1 million | 165000 |
2023-09-30 | -1.3 million | 160000 |
2023-06-30 | -1.5 million | 246000 |
2023-03-31 | -1.8 million | 290000 |
KTRA Net Income
No data available :(
KTRA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 658000 | - | - |
2023-09-30 | 216000 | - | - |
2023-06-30 | 1.5 million | - | - |
2023-03-31 | 3.0 million | - | - |
KTRA Shares Outstanding
KTRA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 20000 | 111000 | 908000 | 15000 |
2023-09-30 | - | 1.9 million | 1.1 million | - |
2023-06-30 | - | 2.1 million | 1.3 million | - |
2023-03-31 | - | 2.0 million | 1.3 million | - |
KTRA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 15000 |
2023-09-30 | - | 15000 |
2023-06-30 | - | 15000 |
2023-03-31 | - | 15000 |
KTRA
Price: $0.14
52 week price:
Earnings Per Share: -5.22 USD
P/E Ratio: -0.01
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 62500
Market Capitalization: 5.8 million